dict.md logo
Results for * in English, page 137
2H,3H,6aH-pyrrolidino(2'',1''-3',2')1,3-oxazino(6',5'-5,4)benzo(e)1, 4-dioxan-10-one
2H,4H-Oxazolo(5,4,3-ij)pyrido(3,2-g)quinoline-4,10(11H)-dione, 6,8-bis(hydroxymethyl)-11-methyl-
2H,5H-Cyclopenta(d')naphtho(1,8-bc:2,3-b')difuran-6-acetic acid, 8-(3-furanyl)-2a,5a,6,6a,8,9,9a,10a,10b,10c-decahydro-2a,5a,6a,7-tetramethyl-5-oxo-, methyl ester, (2aR-(2aalpha,5aalpha,6alpha,6aalpha,8beta,9abeta,10alpha,10balpha,10c.beta))
2H,5H-Pyrano(4,3-b)pyran-2-one, 7,8-dihydro-5-hydroxy-4-methoxy-7,8-dimethyl-
2H,6H-(1,3)thiazino(3,2-b)isoquinolin-6-one, 3,4-dihydro-
2H,6H-1,4,5-Trioxadicyclopent(a,hi)inden-2-one, 3-ethylidene-3,3a,4a,7,7a,9b-hexahydro-6-hydroxy-, (3E,3aalpha,4abeta,6beta,7abeta,9aR*,9bbeta)-(+)-
2H,6H-Benzo(1,2-b:5,4-b')dipyran-2-one, 3-(2,4-dihydroxyphenyl)-7,8-dihydro-8-(hydroxymethyl)-5-methoxy-8-methyl-
2H,6H-Benzo(1,2-b:5,4-b')dipyran-2-one, 7-(acetyloxy)-3-(1,1-dimethyl-2-propenyl)-7,8-dihydro-8-methyl-8-(2-methylpropyl)-, trans-
2H,6H-Benzo(1,2-b:5,4-b')dipyran-6-one, 5-hydroxy-7-(4-hydroxy-3-methoxyphenyl)-2,2-dimethyl-10-(3-methyl-2-butenyl)-
2H,6H-Benzo(1,2-b:5,4-b')dipyran-6-one, 8-(2,4-dihydroxyphenyl)-7,8-dihydro-5-hydroxy-2,2-dimethyl-10-(3-methyl-2-butenyl)-, (S)-
2H,6H-Benzo(1,2-b:5,4-b')dipyran-8-carboxylic acid, 3,4-dihydro-2,2,4,10-tetramethyl-6-oxo-, (5alpha,17alpha)-
2H,6H,10H-Benzo(01,2-b:3,4-b':5,6-b'')tripyran-2-one, 7,8,11,12-tetrahydro-12-hydroxy-6,6,10,11-tetramethyl-4-propyl-, 010S-(10alpha,11beta,12beta)-
2H,6H,10H-Benzo(1,2-b:3,4-b':5,6-b'')tripyran-2-one, 11,12-dihydro-12-hydroxy-6,6,10,11-tetramethyl-4-phenyl-, (10alpha,11beta,12alpha)-(+)-
2H,6H,10H-Benzo(1,2-b:3,4-b':5,6-b'')tripyran-2-one, 11,12-dihydro-12-hydroxy-6,6,10,11-tetramethyl-4-propyl-, (10R-(10alpha,11beta,12alpha))-
2H,6H,10H-Benzo(1,2-b:3,4-b':5,6-b'')tripyran-2-one, 11,12-dihydro-12-hydroxy-6,6,10,11-tetramethyl-4-propyl-, (10R-(10alpha,11beta,12beta))-
2H,8H-Benzo(1,2-b:3,4-b')dipyran-2-one, 9-(acetyloxy)-9,10-dihydro-10-hydroxy-8,8-dimethyl-, (9S-cis)-
2H,9H-isoxazolo(3,2-b)(1,3)benzoxazin-9-one, 7-chloro-3,3a-dihydro-2-methyl-
2H,9H,11H-9,20-Epoxy-1,8a-(epoxymethano)-20,10-methenocyclodecacyclotetradecen-23-one, 1,3,4,7,8,12,15,16,19,20a-decahydro-5,14,18-trimethyl-2-(1-methylethyl)-, (1R*,2S*,5E,8aS*,9R*,13E,17E,20S*,20aS*)-
2H10 peptide
2H2M67B
2H4 Antigens
2H6 antigen, human
2H9
2HAbetaG
2HCl;(cis)-isomer of 1,4-diaminocyclohexane
2HCl;(trans)-isomer of 1,4-diaminocyclohexane
2HCOO-KAAKY-OCH3
2Helicopsyche murrumba Mosely, 1953
2Hexanol Ur-mCnc
2Hexanol/creat Ur-mRto
2HM-HBG
2HMMC cpd
2HO-ACM-B
2HOR0202
2HSB
2HYC cpd
2i
2Im-Py-ABA-3Py-Ala-Dp
2IPDdHEF
2iPrN NSACBzCOO
2IT-BAD Monoclonal Antibody 170
2IT-BAD-Lym-1
2IT-BAD-Lym-1 MoAB
2L8 : too late
2Lt
2M post 0.2 U/kg secretin
2M post 0.5 ug/kg pentagastrin IV
2M post 2 mg/kg calcium & 0.5 ug/kg pentagastrin IV
2M post birth
2M post dose glucagon
2M post XXX challenge
2M-THA
2M3B1pp
2MbisP
2MC-PAF
2MD cpd
2Me-butyrylglycine Ur Ql
2Me-butyrylglycine/creat Ur-mRto
2Me-butyrylglycine/creat Ur-sRto
2Me-citrate Amn-sCnc
2Me-citrate CSF-sCnc
2Me-citrate SerPl-mCnc
2Me-citrate SerPl-sCnc
2Me-citrate Ur Ql
2Me-citrate Ur-mCnc
2Me-citrate Ur-sCnc
2Me-citrate/creat 24H Ur-sRto
2Me-citrate/creat Ur-mRto
2Me-citrate/creat Ur-sRto
2Me-glutaconate/creat Ur-sRto
2Me-glutarate/creat Ur-sRto
2Me-pentane Bld-mCnc
2me-Z7-18Hy
2ME2
2Me2Propanol Bld-mCnc
2Me2Propanol XXX-mCnc
2Me3-oxobutyrate/creat Ur-sRto
2Me3OH-Butyr Acidemias/BKT DBS-Imp
2Me3OH-butyrate Ur Ql
2Me3OH-butyrate/creat 24H Ur-sRto
2Me3OH-butyrate/creat Ur-mRto
2Me3OH-butyrate/creat Ur-sRto
2Me3OH-Butyrcarn Amn-sCnc
2Me3OH-Butyrcarn CSF-sCnc
2Me3OH-Butyrcarn DBS-sCnc
2Me3OH-Butyrcarn SerPl-sCnc
2Me3OH-Butyrcarn Ur-sCnc
2Me3OH-Butyrcarn/creat Ur-sRto
2MeABP-DMEA
2MEM
2MeO-C10COOH
2MeOTI chloride
2Methoxyethanol Bld-mCnc
2MgO.2B2O3.MgCl2.14H2O
2Mo
2MOBA
2MPE(O)pipEt
2N-MePyPs
2N(w)OHC2-Arg
2n/3n mixoploidy
2n/4n mixoploidy
2N3-APE
2N3F-flavone
2N3NAD
2Na of benzene 1,3-disulfonate
2NBz-4CON
2nd
2nd bne ref {Dent arch}
2nd concurrent infusion ther
2nd course biological reponse modifier therapy [Identifier] Cancer Rx
2nd course BRM Cancer Rx
2nd course Chemo Cancer Rx
2nd course chemotherapy [Identifier] Cancer Rx
2nd course Horm Cancer Rx
2nd course hormonal therapy [Identifier] Cancer Rx
2nd course other therapy [Identifier] Cancer Rx
2nd course Other Tx Cancer Rx
2nd course Rad Cancer Rx
2nd course radiation [Identifier] Cancer Rx
2nd course Surg Cancer Rx
2nd course Surg.other reg dis Cancer
2nd course surgery [Identifier] Cancer Rx
2nd course surgery.other regional disease [Identifier] Cancer
2nd course treatment
2nd course treatment | Subsequent Cancer Rx
2nd course treatment Cancer Rx
2nd course treatment start date
2nd course treatment start date | Subsequent Cancer Rx
2nd course treatment start date Cancer Rx
2nd course treatment start date:Time Stamp -- Date and Time:Point in time:Subsequent cancer Rx:Quantitative
2nd course treatment start date:TmStp:Pt:Subsequent cancer Rx:Qn
2nd course treatment:Type:Point in time:Subsequent cancer Rx:Nominal
2nd course treatment:Type:Pt:Subsequent cancer Rx:Nom
2nd course treatment.biological reponse modifier therapy
2nd course treatment.biological reponse modifier therapy | Subsequent Cancer Rx
2nd course treatment.biological reponse modifier therapy:Presence or Identity:Point in time:Subsequent cancer Rx:Nominal
2nd course treatment.biological reponse modifier therapy:Prid:Pt:Subsequent cancer Rx:Nom
2nd course treatment.chemotherapy
2nd course treatment.chemotherapy | Subsequent Cancer Rx
2nd course treatment.chemotherapy:Presence or Identity:Point in time:Subsequent cancer Rx:Nominal
2nd course treatment.chemotherapy:Prid:Pt:Subsequent cancer Rx:Nom
2nd course treatment.hormonal therapy
2nd course treatment.hormonal therapy | Subsequent Cancer Rx
2nd course treatment.hormonal therapy:Presence or Identity:Point in time:Subsequent cancer Rx:Nominal
2nd course treatment.hormonal therapy:Prid:Pt:Subsequent cancer Rx:Nom
2nd course treatment.other therapy
2nd course treatment.other therapy | Subsequent Cancer Rx
2nd course treatment.other therapy:Presence or Identity:Point in time:Subsequent cancer Rx:Nominal
2nd course treatment.other therapy:Prid:Pt:Subsequent cancer Rx:Nom
2nd course treatment.radiation
2nd course treatment.radiation | Subsequent Cancer Rx
2nd course treatment.radiation:Presence or Identity:Point in time:Subsequent cancer Rx:Nominal
2nd course treatment.radiation:Prid:Pt:Subsequent cancer Rx:Nom
2nd course treatment.surgery
2nd course treatment.surgery | Subsequent Cancer Rx
2nd course treatment.surgery:Presence or Identity:Point in time:Subsequent cancer Rx:Nominal
2nd course treatment.surgery:Prid:Pt:Subsequent cancer Rx:Nom
2nd course treatment.surgery.other regional disease
2nd course treatment.surgery.other regional disease | Cancer XXX
2nd course treatment.surgery.other regional disease:Presence or Identity:Point in time:Cancer.To be specified in another part of the message:Nominal
2nd course treatment.surgery.other regional disease:Prid:Pt:Cancer.XXX:Nom
2nd course Tx Cancer Rx
2nd course Tx start date Cancer Rx
2nd deg burn abdomn wall
2nd deg burn ankle
2nd deg burn arm NOS
2nd deg burn arm-mult
2nd deg burn axilla
2nd deg burn back
2nd deg burn breast
2nd deg burn chest wall
2nd deg burn chin
2nd deg burn ear
2nd deg burn elbow
2nd deg burn eye
2nd deg burn face NEC
2nd deg burn finger
2nd deg burn foot
2nd deg burn forearm
2nd deg burn genitalia
2nd deg burn hand NOS
2nd deg burn hand-mult
2nd deg burn head NOS
2nd deg burn head-mult
2nd deg burn knee
2nd deg burn leg NOS
2nd deg burn leg-mult
2nd deg burn lip
2nd deg burn lower leg
2nd deg burn mult finger
2nd deg burn mult site
2nd deg burn neck
2nd deg burn nose
2nd deg burn palm
2nd deg burn scalp
2nd deg burn scapula
2nd deg burn shoulder
2nd deg burn thigh
2nd deg burn thumb
2nd deg burn toe
2nd deg burn trunk NEC
2nd deg burn trunk NOS
2nd deg burn upper arm
2nd deg burn wrist
2ND DEGREE AV BLOCK
2nd degree burn NOS
2nd degree sunburn
2nd facial landmark Head
2nd Grade
2nd Grade Completion
2nd interdent papilla boundary {Tooth}
2nd IRP
2nd non-Operative
2nd op post eye rem NEC
2nd Operative
2nd opinion ordered by PRO
2nd part of the duodenum
2nd skin
2nd specimen
2nd specimen post CFst
2nd specimen post dose gonadotropin releasing hormone
2nd specimen post dose lactose
2nd specimen post dose sincalide
2nd specimen post exercise
2nd specimen post XXX challenge
2nd specimen/1st specimen
2nd tooth space boundary
2nd trimester 3 screen Pnl SerPl
2nd trimester 3 screen Ser-Imp
2nd trimester 3 screen SerPl-Imp
2nd trimester 4 screen Pnl SerPl
2nd trimester 4 screen Ser-Imp
2nd trimester 5 screen Pnl SerPl
2nd trimester 5 screen SerPl-Imp
2nd World War
2nd World Wars
2nd-5th toe middle phalangeal hypoplasia
2nd/subsqnt drg multi drg ud
2ndry exent cavity graft
2ndry ocular imp insert
2NPOH cpd
2nPQ cpd
2NT dioxygenase
2NTCDD
2NTX-99
2NUBTA
2OH-adipate/creat 24H Ur-sRto
2OH-adipate/creat Ur-mRto
2OH-adipate/creat Ur-sRto
2OH-estrone SerPl-mCnc
2OH-estrone/16-alphaOHestrone SerPl-mRto
2OH-gluterate 24H Ur Ql
2OH-gluterate Ur Ql
2OH-gluterate/creat 24H Ur-sRto
2OH-gluterate/creat Ur-mRto
2OH-gluterate/creat Ur-sRto
2OH-isobutyrate Ur Ql
2OH-isobutyrate/creat Ur-sRto
2OH-isocaproate Ur Ql
2OH-isocaproate/creat 24H Ur-mRto
2OH-isocaproate/creat 24H Ur-sRto
2OH-isocaproate/creat Ur-mRto
2OH-isocaproate/creat Ur-sRto
2OH-isovalerate Ur Ql
2OH-isovalerate/creat 24H Ur-sRto
2OH-isovalerate/creat Ur-mRto
2OH-isovalerate/creat Ur-sRto
2OH-phenylacetate Ur Ql
2OH-phenylacetate/creat Ur-mRto
2OH-phenylacetate/creat Ur-sRto
2OH-sebacate/creat Ur-sRto
2OH-valerate/creat Ur-mRto
2OH+16-alphaOH estrone Pnl SerPl
2OH3Me-valerate Ur Ql
2OH3Me-valerate/creat 24H Ur-sRto
2OH3Me-valerate/creat Ur-mRto
2OH3Me-valerate/creat Ur-sRto
2OHSS-dione
2ONITOR, BREATHING FREQUENCY
2OST
2Oxo-adipate/creat Ur-mRto
2Oxo-adipate/creat Ur-Rto
2Oxo-adipate/creat Ur-sRto
2Oxo3Me-valerate SerPl-sCnc
2Oxo3Me-valerate Ur Ql
2Oxo3Me-valerate/creat 24H Ur-sRto
2Oxo3Me-valerate/creat Ur-mRto
2Oxo3Me-valerate/creat Ur-sRto
2Oxoisocaproate Dose
2Oxoisocaproate SerPl-sCnc
2Oxoisocaproate Ur Ql
2Oxoisocaproate Ur-mCnc
2Oxoisocaproate/creat 24H Ur-sRto
2Oxoisocaproate/creat Ur-mRto
2Oxoisocaproate/creat Ur-sRto
2Oxoisovalerate SerPl-sCnc
2Oxoisovalerate Ur Ql
2Oxoisovalerate/creat 24H Ur-sRto
2Oxoisovalerate/creat Ur-mRto
2Oxoisovalerate/creat Ur-sRto
2oxoquaz
2p
2p deletion syndrome
2p duplication syndrome
2p- syndrome
2p+ syndrome
2P1
2p11
2p12
2p12-p13
2p13
2p13-p12
2p13-q13
2p13.1
2p13.2
2p14-p13
2p14.1
2p15
2p16
2p16-p21
2p16.1
2p16.3
2p21
2p21del syndrome is a contiguous gene syndrome caused by 179kb deletion containing the SLC3A1 ({104614}), PREPL ({609557}), PPM1B ({603770}), and C2orf34 ({609559}) genes
2p22-p21
2p22.3-p21
2p23
2p23-p22
2p23.3
2p23.3-p23.2
2p24
2p24.1
2p24.3-q21.3
2p25
2p25-p24
2p25.1
2p25.3
2pd
2PEG-avidin-biotin-PEI8
2PhEt-FBPMA
2pm
2PP2A
2Pro-TAZ
2pter-p12
2PTmin3.2 ribozyme
2PTS sodium
2PY cpd
2PY-e cpd
2Py(3)2Py
2Pyridone Dose
2Pyridone SerPl-mCnc
2Pyridone/NMN SerPl-mRto
2q
2q deletion syndrome
2q duplication syndrome
2q- syndrome
2q+ syndrome
2q11.2-q12
2q12
2q12-q14
2q12-q22
2q12.2
2q12.3
2q14
2q14.1
2q21
2q21-q22
2q21.1
2q22
2q22-q23
2q22-q24
2q22.2-q23.3
2q23
2q23-q24
2q31
2q31-q32
2q31-q33
2q31.1
2q31.2
2q31.2-q33.1
2q32
2q32.2
2q32.2-q32.3
2q33
2q33-q34
2q33-q36
2q33-q37
2q33.1
2q33.3-q34
2q34
2q34-q35
2q35
2q35-q36
2q35-q37
2q36
2q36-q37
2q36.1
2q36.3
2q37
2q37.1
2q37.2
2QN-echinomycin
2R-(2alpha,5beta)(R*)-isomer of hinesol
2R-(alpha(4R*,8R*),8abeta)-isomer of 8-hydroperoxytocopherone
2R-(n-butyl)-16-methyl-3S,5S,7S,9R,11R,13R,15S,26S, 27R-nonahydroxyoctacosa-16,18,20,22,24-pentaenoic acid, 27-lactone
2R-trans)-2-(3,4-dihydroxyphenyl)-3,4-dihydro-2H-1-benzopyran-3,5,7-triol
2R,3R-trans-aromadendrin-7-O-beta-D-glucopyranoside-6''-(4''-hydroxy-2''-methylene butanoate)
2R,3R)-2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-chroman-3-yl] 3,4,5-trihydroxybenzoate
2R,3R)-2-(3,4,5-trihydroxyphenyl)-5,7-dihydroxy-chroman-3-yl] 3,4,5-trihydroxybenzoate
2R,3R)-2-(3,4,5-trihydroxyphenyl)chroman-3,5,7-triol
2R,3S)-2-(3,4-dihydroxyphenyl)chroman-3,5,7-triol
2R,3S)-2-(3,4,5-trihydroxyphenyl)chroman-3,5,7-triol
2R,4R-4-aminopyrrolidine-2,4-dicarboxylate
2R,4R-APDC
2R(-)-cis-HMD-cytosine
2R(-)-trans-HMD-cytosine
2s
2S albumin precursor protein, Ricinus communis
2S albumin precursor, Bertholletia excelsa
2S albumin, brazil nut
2S Albumins, Plant
2S Storage Albumins, Plant
2S storage protein, Ricinus communis
2S sulfur-rich seed storage protein, Bertholletia excelsa
2S-(3,4-dihydroxy-5-methoxyphenyl)-3R-hydroxymethyl-2,3-dihydro-1,4,5-trioxa-anthracen-6-one
2S-(4-methyl-3-pentenyl)-5-hydroxy-6-formyl-2,7-dimethyl-2H-chromene
2S-(4-methyl-3-pentenyl)-6-formyl-8-hydroxy-2,7-dimethyl-2H-chromene
2S-2',5,7-trihydroxy-4',5'-(2,2-dimethylchromeno)-6-prenyl flavanone
2S-hydroxymutilin
2S-isocapryloyl-3S-hydroxymethyl-gamma-butyrolactone
2S-methyl-4S-phenylpyrrolidine
2S-MMF
2S-tetrahydro-2 alpha(E)-(1-nonene-3,5,7-triynyl)- 2H-pyran-3 beta-ol
2s, Hyperlipoproteinemia Type
2s, Mucopolysaccharidosis Type
2s, Neurofibromatosis Type
2S,3R,4E,8E-1-(beta-D-glucopyranosyl)-3-hydroxy-2-((R)-2'-hydroxyheptadecanoyl)amino-9-methyl-4,8-octadecadiene
2S,3R)-2-Amino-3-hydroxybutanoic acid
2S,3S)-2-Amino-3-methylpentanoic acid
2S,4R-4-methylglutamate
2tBuTHA
2W
2X cpd
2x2 table
2x2 tables
2Z,4E-alpha-ionylideneethane
3
3 (2-acetamidoethylsulfinyl)-6-(1-hydroxysulfonyloxy-1-methylethyl)-7-oxo-1-azabicyclo(3.2.0)hept-2-ene-2-carboxylic acid
3 (3-(6-benzoyloxy-3-cyano-2-pyridyloxycarbonyl)benzoyl)-1-ethoxymethyl-5-fluorouracil
3 (or 17)-beta-hydroxysteroid dehydrogenase
3 [sc_ap]
3 5 CYCL NPD
3 ACTUAT HYLAN G-F 20 16 MG/ACTUAT Prefilled Syringe
3 alpha Fucosyl N Acetyl Lactosamine
3 alpha Hydroxy 5 alpha Androstan 17 One
3 alpha Hydroxy 5 alpha pregnan 20 one
3 alpha Hydroxy 5 beta Androstan 17 One
3 alpha Hydroxy 5 beta pregnan 20 one
3 alpha hydroxy-4 beta,8 alpha,15-triacetoxy-12,13-epoxytrichothec-9-ene
3 alpha Hydroxysteroid Dehydrogenase
3 alpha Hydroxysteroid Oxidoreductase
3 alpha-acetoxy-7 alpha,15 alpha-oxido-16-oxa-5 beta,14 beta-androstan-17-one
3 alpha-amino-14-hydroxy-16 beta-acetoxy-5 beta,14 beta-card-20(22)-enolide
3 alpha-amino-3-desoxyoleandrigenin
3 alpha-amino-5 alpha-androstan-2 beta-ol-17-one.HCl
3 alpha-amino-5 beta-cholan-24-oic acid
3 alpha-beta, 20 beta-hydroxysteroid dehydrogenase
3 alpha-bromoacetoxyandrosterone
3 alpha-dimethylamino-5 alpha-androstan-2 beta-ol-17-one
3 alpha-diol G
3 alpha-fluoro-9,10-secocholestatrien-5,7,10(19)
3 alpha-Fucosyl-N-Acetyl Lactosamine
3 alpha-galactosylated alpha-GalCer
3 alpha-hydroxy-1-methylene-5 alpha-androstan-17-one
3 alpha-hydroxy-12-keto-5 beta-cholanoic acid
3 alpha-hydroxy-16-imino-17-aza-5 beta-androstan-11-one
3 alpha-hydroxy-17-methyl-18-nor-5beta-androst-13(17)-ene-16-one
3 alpha-hydroxy-3,25-epoxylup-20(29)-en-28-oic acid
3 alpha-hydroxy-3,5-dihydromonacolin L
3 alpha-hydroxy-4-androsten-17-one
3 alpha-hydroxy-4-pregnen-20-one
3 alpha-hydroxy-5 alpha-androstane-11,17-dione
3 alpha-hydroxy-5 alpha-pregna-9(11),16-diene-20-one
3 alpha-Hydroxy-5 alpha-pregnan-20-one
3 alpha-hydroxy-5 alpha-pregnane-11,20-dione
3 alpha-hydroxy-5 alpha-spirostan-2,12-dione
3 alpha-hydroxy-5 beta-6-cholen-24-oic acid
3 alpha-hydroxy-5 beta-androstan-17 beta-carboxylic acid
3 alpha-hydroxy-5 beta-androstane-7,17-dione
3 alpha-hydroxy-5 beta-chol-11-en-24-oic acid
3 alpha-hydroxy-5 beta-chol-6-en-24-oic acid
3 alpha-hydroxy-5 beta-cholestan-26-oic acid
3 alpha-hydroxy-5 beta-cholestan-27-al
3 alpha-hydroxy-5 beta-etianic acid
3 alpha-Hydroxy-5 beta-pregnan-20-one
3 alpha-hydroxy-5 beta,14 beta-chol-8-en-24-oic acid
3 alpha-hydroxy-5alpha-pregnan-20-one sulfate
3 alpha-hydroxy-6-fluoroindoline
3 alpha-hydroxy-6,19-oxidopregn-4-ene-20-one
3 alpha-hydroxy-7 epsilon-methyl-5 beta-cholanoic acid
135 136 137 138 139